Better Therapeutics

(OTC) BTTX

Current Price$0.00

Market Cap$5,400

Since IPO (2021)-100%

5 Year-100%

1 Year-50%

1 Month+0%

Better Therapeutics Financials at a Glance

Market Cap

$5,400

Revenue (TTM)

$0.00

Net Income (TTM)

$31.57M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-16.06 (Low)

Dividend

$0.00

Beta (Volatility)

-16.06 (Low)

Price

$0.00

Volume

Open

$0.00

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Dividend

$0.00

Beta (Volatility)

-16.06 (Low)

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

BTTX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Better Therapeutics

Industry

Health Care Technology

Sector

Health Care

Employees

CEO

Frank L. Karbe, MBA

Website

www.bettertx.com

Headquarters

San Francisco, CA 94104, US

BTTX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-4%

Return on Assets

-2%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.40K

Shares Outstanding

54.35M

Volume

Avg. Volume

3.65K

Financials (TTM)

Gross Profit

$2.73M

Operating Income

$38.26M

EBITDA

$38.21M

Operating Cash Flow

$28.93M

Capital Expenditure

$1.18M

Free Cash Flow

$30.11M

Cash & ST Invst.

$15.74M

Total Debt

$14.88M

Better Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2023YOY CHG

Revenue

$0.00

N/A

Gross Profit

$841.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$5.40K

N/A

Market Cap/Employee

$100.00

N/A

Employees

N/A

Net Income

$5.86M

+48.6%

EBITDA

$4.50M

+56.3%

Quarterly Fundamentals

Name

Q3 2023YOY CHG

Net Cash

$7.71M

-202.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$7.72M

-33.8%

Short Term Debt

$6.59M

+110.5%

Return on Assets

-1.73%

N/A

Return on Invested Capital

-4.05%

N/A

Free Cash Flow

$5.95M

+19.5%

Operating Cash Flow

$5.94M

+15.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PANCPanacos Pharmaceuticals, Inc.

PANCPanacos Pharmaceuticals, Inc.$0.00+0.00%

SCIESpectraScience, Inc.

SCIESpectraScience, Inc.$0.00+0.00%

AMPEAmpio Pharmaceuticals, Inc.

AMPEAmpio Pharmaceuticals, Inc.$0.01+0.00%

BXRXQBaudax Bio, Inc.

BXRXQBaudax Bio, Inc.$0.00+0.00%

KLDOKaleido Biosciences, Inc.

KLDOKaleido Biosciences, Inc.$0.00+0.00%

UPPRUpper Street Marketing Inc.

UPPRUpper Street Marketing Inc.$0.00+0.00%

TLOGTetraLogic Pharmaceuticals Corporation

TLOGTetraLogic Pharmaceuticals Corporation$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.02-0.08%

Questions About BTTX

What is the current price of Better Therapeutics?

Better Therapeutics is trading at $0.00 per share.

What is the 52-week range for Better Therapeutics?

Over the past 52 weeks, Better Therapeutics has traded between $0.00 and $0.00.

How much debt does Better Therapeutics have?

As of the most recent reporting period, Better Therapeutics reported total debt of $14.88M.

How much cash does Better Therapeutics have on hand?

Better Therapeutics reported $15.74M in cash and cash equivalents in its most recent financial results.

What is Better Therapeutics’s dividend yield?

Better Therapeutics does not currently have a dividend yield.

Better Therapeutics

Better Therapeutics Financials at a Glance

BTTX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Better Therapeutics

BTTX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Better Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BTTX

What is the current price of Better Therapeutics?

What is the 52-week range for Better Therapeutics?

How much debt does Better Therapeutics have?

How much cash does Better Therapeutics have on hand?

What is Better Therapeutics’s dividend yield?

Premium Investing Services